PP
COGT icon

PDT Partners’s Cogent Biosciences COGT Stock Holding History

PDT Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,668
Closed -$170K – 605
2025
Q2 		$170K Hold
23,668
– – 0.01% 648
2025
Q1 		$142K Sell
23,668
-56
-0.2% -$439 0.01% 703
2024
Q4 		$185K Sell
23,724
-29,992
-56% -$299K 0.02% 666
2024
Q3 		$580K Hold
53,716
– – 0.05% 473
2024
Q2 		$453K Buy
53,716
+30,000
+126% +$228K 0.04% 488
2024
Q1 		$159K Buy
+23,716
New +$147K 0.02% 589

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

PDT Partners's COGT Position: Q3 2025 in Review

PDT Partners sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 23,668 shares — an estimated $170K sold.

PDT Partners first reported a position in COGT in Q1 2024 and held it in 6 quarters. The position peaked at $580K in Q3 2024. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • PDT Partners reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 23,668 Cogent Biosciences shares in Q3 2025, an estimated $170K.
  • PDT Partners first reported a position in Cogent Biosciences in Q1 2024 and held it in 6 quarters.
  • PDT Partners's Cogent Biosciences position peaked at $580K in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.